ATE520405T1 - Inhalationszusammensetzung - Google Patents

Inhalationszusammensetzung

Info

Publication number
ATE520405T1
ATE520405T1 AT03751884T AT03751884T ATE520405T1 AT E520405 T1 ATE520405 T1 AT E520405T1 AT 03751884 T AT03751884 T AT 03751884T AT 03751884 T AT03751884 T AT 03751884T AT E520405 T1 ATE520405 T1 AT E520405T1
Authority
AT
Austria
Prior art keywords
microns
diameter
less
inhalation composition
lactose particles
Prior art date
Application number
AT03751884T
Other languages
English (en)
Inventor
Xian-Ming Zeng
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35140632&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE520405(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0219513A external-priority patent/GB0219513D0/en
Priority claimed from GB0219514A external-priority patent/GB0219514D0/en
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Application granted granted Critical
Publication of ATE520405T1 publication Critical patent/ATE520405T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03751884T 2002-08-21 2003-08-21 Inhalationszusammensetzung ATE520405T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0219513A GB0219513D0 (en) 2002-08-21 2002-08-21 Inhalation compositions including coarse carrier
GB0219514A GB0219514D0 (en) 2002-08-21 2002-08-21 Inhalation compositions including fine carrier
PCT/US2003/026385 WO2004017914A2 (en) 2002-08-21 2003-08-21 Inhalation composition

Publications (1)

Publication Number Publication Date
ATE520405T1 true ATE520405T1 (de) 2011-09-15

Family

ID=35140632

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03751884T ATE520405T1 (de) 2002-08-21 2003-08-21 Inhalationszusammensetzung

Country Status (9)

Country Link
US (1) US8273331B2 (de)
EP (1) EP1599209B1 (de)
KR (1) KR101369631B1 (de)
AT (1) ATE520405T1 (de)
AU (1) AU2003269989B8 (de)
EA (1) EA007377B1 (de)
IL (1) IL167009A (de)
MX (1) MXPA05001903A (de)
NZ (1) NZ538965A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
DE602004031459D1 (de) 2003-09-02 2011-03-31 Norton Healthcare Ltd Verfahren zur herstellung eines medikaments
EP1848444B1 (de) * 2005-02-10 2016-11-09 Glaxo Group Limited Verfahren zur herstellung von lactose unter verwendung von vorklassifizierungsverfahren sowie damit erzeugte pharmazeutische formulierungen
KR101252001B1 (ko) * 2006-06-15 2013-04-08 삼성디스플레이 주식회사 액정 표시 장치 및 그 제조 방법
GB0714134D0 (en) * 2007-07-19 2007-08-29 Norton Healthcare Ltd Dry-powder medicament
US20110262502A1 (en) * 2010-02-08 2011-10-27 Prairie Pharmaceuticals LLC Pulmonary delivery of 17-hydroxyprogesterone caproate (17-hpc)
NZ604983A (en) * 2010-06-22 2014-07-25 Chiesi Farma Spa Dry powder formulation comprising an antimuscarinic drug
EP2821062A1 (de) * 2013-07-01 2015-01-07 Arven Ilac Sanayi Ve Ticaret A.S. Neue pharmazeutische Pulverinhalatoren für Atemwege
CN113768881A (zh) 2013-10-08 2021-12-10 人工智能治疗公司 用于治疗淋巴管平滑肌瘤病的雷帕霉素
DK3125875T3 (da) 2014-04-04 2023-07-24 Ai Therapeutics Inc Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
JP6251667B2 (ja) 2014-06-03 2017-12-20 アサヒカルピスウェルネス株式会社 錠剤型即放性製剤及びその製造方法
EP3209330B1 (de) * 2014-10-07 2022-02-23 AI Therapeutics, Inc. Inhalierbare sirolimus formulierung zur behandlung von pulmonaler hypertonie

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
IN166447B (de) * 1985-11-27 1990-05-12 Ethicon Inc
GB9027234D0 (en) 1990-12-15 1991-02-06 Harris Pharma Ltd An inhalation device
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700136D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP0876814A1 (de) 1997-05-07 1998-11-11 "PHARLYSE", Société Anonyme Trägerstoff für Trockenpulverinhalator, Verfahren zu dessen Herstellung und diesen enthaltende Arzneimittel
GB9807232D0 (en) * 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US5965622A (en) * 1998-06-23 1999-10-12 Sepracor Inc. Desformoterol and process for its preparation
CN1150895C (zh) * 1998-11-13 2004-05-26 杰格研究股份公司 用于吸入给药的干粉
WO2000035417A1 (en) * 1998-12-11 2000-06-22 Pharmachemie B.V. Pharmaceutical preparation for inhalation of an opioid
GB9903759D0 (en) 1999-02-18 1999-04-14 Novartis Ag Organic compounds
IT1309592B1 (it) * 1999-03-05 2002-01-24 Chiesi Farma Spa Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
WO2000053157A1 (en) 1999-03-05 2000-09-14 Chiesi Farmaceutici S.P.A. Improved powdery pharmaceutical compositions for inhalation
GB9928311D0 (en) 1999-11-30 2000-01-26 Novartis Ag Organic compounds
WO2001051030A1 (en) * 2000-01-10 2001-07-19 Dura Pharmaceuticals, Inc. Pharmaceutical formulation and method for pulmonary and oral delivery
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
OA12522A (en) * 2000-10-12 2006-05-30 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder.
US7008644B2 (en) * 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
US20050158248A1 (en) * 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
GB0219512D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions with high drug ratios
DE602004031459D1 (de) * 2003-09-02 2011-03-31 Norton Healthcare Ltd Verfahren zur herstellung eines medikaments

Also Published As

Publication number Publication date
EP1599209A4 (de) 2009-07-08
AU2003269989B8 (en) 2009-11-12
EA007377B1 (ru) 2006-10-27
NZ538965A (en) 2006-11-30
AU2003269989A1 (en) 2004-03-11
EA200500389A1 (ru) 2005-12-29
EP1599209A2 (de) 2005-11-30
AU2003269989B2 (en) 2009-11-05
US8273331B2 (en) 2012-09-25
US20040258626A1 (en) 2004-12-23
EP1599209B1 (de) 2011-08-17
IL167009A (en) 2014-06-30
KR101369631B1 (ko) 2014-03-05
MXPA05001903A (es) 2005-04-28
KR20050083648A (ko) 2005-08-26

Similar Documents

Publication Publication Date Title
ATE520405T1 (de) Inhalationszusammensetzung
MXPA02012023A (es) Administracion altamente eficiente de un aerosol de masa terapeutica grande.
TNSN05047A1 (en) Inhalation composition
ATE271383T1 (de) Pulverformulierung zur inhalation
PT2174653E (pt) Formulações para inalador de pó seco compreendendo partículas modificadas na superfície com aditivos antiaderentes
FI20002215A0 (fi) Yhdistelmäpartikkelit
AR039276A1 (es) Metodo para la administracion de un anticolinergico por inhalacion
HUP0203885A2 (hu) Új, tiotropium-tartalmú inhalációs por, eljárás az előállítására és alkalmazására
ATE241961T1 (de) Modifizierte trägerpartikel zur verwendung in trockenpulverinhalatoren
ATE494030T1 (de) Pulverinhalator
TNSN05046A1 (en) Method of preparing dry powder inhalation compositions
ATE453382T1 (de) Pulver zur nasalen verabreichung von wirkstoffen
ZA202201322B (en) Pharmaceutical composition comprising ensifentrine
MXPA05009629A (es) Composiciones que contienen trospio.
FI20002216A0 (fi) Yhdistelmäpartikkelit astman hoitoon
MX2025008306A (es) Polvos secos inhalables
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
EA200500387A1 (ru) Композиции для ингаляции с высоким содержанием лекарственных веществ
WO2006041538A3 (en) A mixture for transdermal delivery of low and high molecular weight compounds
EA200900464A1 (ru) Фармацевтическая композиция для ингаляции
MY140890A (en) New tiotropium containing powder formulation for inhalation
DE60221640D1 (de) Bimodale trockenpulverzusammensetzung zur inhalation
TW200730170A (en) Micronised azodicarbonamide, and the preparation and use thereof
PH12012501512A1 (en) Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
MEP1908A (xx) Gabaksadol za liječenje depresije i drugih afektivnih poremećaja

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties